Sign Out
Prevention of venous thromboembolic events (VTE) in adult patients who have undergone elective hip or knee replacement surgery.
Prevention of stroke and systemic embolism in adult patients with non-valvular atrial fibrillation (NVAF) with one more risk factor, including patients unsuitable for warfarin. Compared to warfarin.
Treatment of deep vein thrombosis (DVT) and pulmonary embolism (PE).
Prevention of recurrent DVT and PE.
Continue with Google